In the U.S., medications are priced and sold by the pill, capsule or fluid ounce. A better approach would be to charge different prices for a medicine based on the disease for which it is prescribed. While the current drug-purchasing system is too complex to reform overnight, there is a simple change that could improve health outcomes and control spending: disease-specific rebates.
- The Contribution of New Product Entry Versus Existing Product Inflation in the Rising Costs of Drugs
- Court Issues Permanent Injunction Blocking Medicare 340B Payment Cuts